Clinical Trial Supplies Market Analysis Report 2025-2029: Breakdown by Manufacturing, Sourcing, Packaging, Labelling, Logistics, Small Molecules, Biologics, Vaccines

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The global Clinical Trial Supplies market is poised to reach USD 8.18 billion by 2030 from USD 5.34 billion in 2025, exhibiting a CAGR of 8.9%

The report offers comprehensive market analysis by services, phase, type, therapeutic area, and end users. Detailed insights into key industry players, market dynamics, emerging technologies, and competitive landscapes are provided. It highlights potential market opportunities, including the rise in decentralized and direct-to-patient trials and challenges such as managing global supply chains.

This growth is fueled by the growing complexity and volume of global clinical trials, increasing personalized medicine initiatives, and stringent regulatory requirements. Advances in decentralized and adaptive trial designs are sparking demand for specialized supply chain solutions, including direct-to-patient logistics and just-in-time inventory management. As biologics and cell & gene therapies become more prevalent, there is an increasing need for temperature-controlled storage and distribution solutions. Furthermore, digitalization through IoT-enabled tracking and AI-driven demand forecasting is enhancing supply chain efficiency.

By capturing insights on market drivers, restraints, opportunities, and challenges, the report assists market leaders and new entrants in making strategic decisions and understanding market pulse. This strategic knowledge aids stakeholders in crafting effective go-to-market strategies and positioning their businesses optimally.

Logistics & Distribution Services Lead the Market

The market segmentation by services highlights Logistics & Distribution Services reigning in 2024, while Sourcing & Procurement Services are expected to grow at a higher CAGR. This trend is due to the increasing complexity of trial protocols and the globalization of clinical studies, prompting sponsors and CROs to outsource procurement to specialized vendors to ensure regulatory compliance, mitigate supply risks, and optimize inventory management.

Phase III Trials Dominate Segmenting by phase, Phase III trials took the lead in 2024. The surge in biologics, cell & gene therapies, and personalized medicine has increased demand for specialized solutions in Phase III trials. The Phase II segment is projected to experience significant growth, attributed to the rising focus on innovative therapies such as biologics, gene therapies, and targeted drugs, necessitating comprehensive Phase II trials to assess efficacy and optimal dosing.

Pharmaceutical & Biotechnology Companies at the Forefront

Within the end-user segment, pharmaceutical and biotechnology companies hold sway. Their continuous expansion of R&D pipelines, escalating investments in innovative therapies, and globalization of clinical trials reinforce their dominance. Meanwhile, CROs and CDMOs are incorporating digital technologies like AI-driven supply chain optimization and blockchain for traceability to boost efficiency and compliance.

North America's Market Leadership

The market segmentation by region shows North America leading in 2024, a trend expected to persist. The US positions itself at the forefront with leading academic and research institutions and substantial biotechnology investments. The adoption of decentralized trials, advanced cold chain logistics, and direct-to-patient delivery models strengthens the US market. North America's established clinical trial infrastructure, advanced healthcare systems, and significant government funding cement its leadership.

APAC is anticipated to witness robust growth due to continuous improvements in healthcare infrastructure, favorable government policies, and heightened outsourcing trends in clinical trial supplies.

In-Depth Market Insights

Extensive interviews with CEOs, Directors, and executives from key organizations in the Clinical Trial Supplies market provided insights into market dynamics, including a 70% focus on supply-side respondents and 30% on the demand side. Prominent market operators include Almac Group (UK), Novo Holdings A/S (Denmark), Marken (UPS) (US), Thermo Fisher Scientific Inc. (US), Clinigen Limited (UK), and many others.

Key Attributes:

Market Dynamics

• Drivers
  • Growth in Clinical Trials & Drug Development
  • Expansion of Global and Multicenter Trials Accelerating Demand for Clinical Trial Supplies
  • Rising Demand for Personalized Medicine and Biologics
• Restraints
  • High Costs Associated with Clinical Trial Supplies
• Opportunities
  • Rise in Decentralized and Virtual Trials
  • Integration of Digital Technologies in Supply Chain Management
• Challenges
  • Supply Chain Disruptions and Drug Shortages

Company Profiles

• Thermo Fisher Scientific Inc.
• Novo Holdings A/S
• United Parcel Service of America, Inc.
• Eurofins Scientific
• Piramal Pharma Limited
• Iqvia
• Icon PLC
• Lonza
• Uniphar Group PLC
• Almac Group
• Sharp Services, LLC
• Pci Pharma Services
• Parexel International (Ma) Corporation
• Biocair
• Cencora, Inc.
• Clinigen Limited
• Klifo
• Ips Pharma
• Corex Logistics Limited
• Oct Group LLC
• Myonex
• Inceptua Group
• Ancillare, Lp
• Adallen Pharma
• Clinical Services International (Csi)
• Nuvisan GmbH
• Aenova Holding GmbH

For more information about this report visit https://www.researchandmarkets.com/r/nmtuk0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Clinical Trial Supplies Market